PRETZEL THERAPEUTICS

Pretzel was founded by some of the world's foremost researchers in mitochondrial biology and is led by accomplished experts in drug discovery, drug development and company foundation. Our deep expertise enables us to potentially address the underlying drivers for a wide range of mitochondrial diseases... Pretzel is supported by a group of distinguished global investors who share our mission of developing groundbreaking therapies for patients who suffer from devastating diseases of mitochondrial dysfunction... Mitochondrial disease results from cells not being able to make the energy required for organs to function properly and leads to a variety of life-altering, and often life-threatening, syndromes. Deficiency in mitochondrial DNA (mtDNA) is a common cause of mitochondrial disease, and Pretzel is designing a portfolio of programs to upregulate mtDNA to improve survival, function and quality of life.

Also known as: Pretzel, Pretzel Therapeutics, Inc.

Primary location: Waltham United States